Pheast Therapeutics
Pheast Therapeutics is a startup headquartered in Redwood City, United States, founded in 2020. It has raised at least $75.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Pheast Therapeutics has raised at least $75.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Pheast Therapeutics sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in Redwood City
- Altos Labs
- Barrel Reserve Technologies
- BlueVine
- Collov
- Find Solace
- Hadron Energy
- Orange Charger
- Petal Surgical
- Skeema
- Stem Cell Theranostics
Related
- Innovation profile of Redwood City
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Pheast Therapeutics do?
Pheast Therapeutics is classed in technology in its filings with the US Securities and Exchange Commission.
How much has Pheast Therapeutics raised?
At least $75.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Pheast Therapeutics based?
Pheast Therapeutics is headquartered in Redwood City, United States.
When was Pheast Therapeutics founded?
Pheast Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.